DLL4 and neoplasm: On the other hand, Dll4-driven Notch activation might reduce both tumor-induced angiogenesis and endothelial cell responsiveness to VEGF (135), and therefore argue rather for the use of Dll4 as an effective therapeutic approach in cancers.